Xenon Pharmaceuticals chair Simon Pimstone and director Mohammad Azab not standing for re-election

Xenon Pharmaceuticals Inc.

Chair Simon Pimstone and board member Mohammad Azab will not stand for re-election at 2024 annual meeting.
Both directors will continue to serve until the AGM; departures are not due to any disagreement with company.
No replacements announced yet; board size and composition will change after AGM.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mohammad Azab

Member of the Board

XENE · Xenon Pharmaceuticals Inc.

Filed: April 19, 2024, 7:59 PM ET

On April 15, 2024, Dr. Simon Pimstone, chair of the board of directors (the “Board”) of Xenon Pharmaceuticals Inc. (the “Company”), and Dr. Mohammad Azab, a member of the Board, each informed the Company of their respective decisions not to stand for re-election to the Board at the Company’s 2024 annual meeting of shareholders (the “AGM”).

Departed

Simon Pimstone

Chair of the Board

XENE · Xenon Pharmaceuticals Inc.

Filed: April 19, 2024, 7:59 PM ET

On April 15, 2024, Dr. Simon Pimstone, chair of the board of directors (the “Board”) of Xenon Pharmaceuticals Inc. (the “Company”), and Dr. Mohammad Azab, a member of the Board, each informed the Company of their respective decisions not to stand for re-election to the Board at the Company’s 2024 annual meeting of shareholders (the “AGM”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mohammad Azab departed as Member of the Board at Xenon Pharmaceuticals Inc..

Action: not stand for re-election
Role: Member of the Board

Exact text from the filing

On April 15, 2024, Dr. Simon Pimstone, chair of the board of directors (the “Board”) of Xenon Pharmaceuticals Inc. (the “Company”), and Dr. Mohammad Azab, a member of the Board, each informed the Company of their respective decisions not to stand for re-election to the Board at the Company’s 2024 annual meeting of shareholders (the “AGM”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Simon Pimstone departed as Chair of the Board at Xenon Pharmaceuticals Inc..

Action: not stand for re-election
Role: Chair of the Board

Exact text from the filing

On April 15, 2024, Dr. Simon Pimstone, chair of the board of directors (the “Board”) of Xenon Pharmaceuticals Inc. (the “Company”), and Dr. Mohammad Azab, a member of the Board, each informed the Company of their respective decisions not to stand for re-election to the Board at the Company’s 2024 annual meeting of shareholders (the “AGM”).

View on SEC.gov

Xenon Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-046023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.